1
STATE OF OKLAHOMA
1
2
1st Session of the 60th Legislature (2025)
2
3
SENATE BILL 801 By: Deevers
3
4
4
5
5
6
AS INTRODUCED
6
7
An Act relating to pharmaceutical companies; creating
7
the Oklahoma Medicine Injury Justice Act; providing
8
short title; stating legislative findings and
8
declarations; defining terms; making pharmaceutical
9
companies liable for certain damages; authorizing
9
certain criminal prosecution; specifying
10
applicability of certain immunities and sovereignty;
10
providing for due process; specifying venue;
11
providing certain construction; providing for
11
noncodification; providing for codification;
12
providing an effective date; and declaring an
12
emergency.
13
13
14
14
15
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
15
16
SECTION 1. NEW LAW A new section of law not to be
16
17
codified in the Oklahoma Statutes reads as follows:
17
18
A. This Act shall be known and may be cited as the “Oklahoma
18
19
Medicine Injury Justice Act”.
19
20
B. The Legislature of the State of Oklahoma finds and declares
20
21
the following:
21
22
1. State Sovereignty: The Tenth Amendment to the United States
22
23
Constitution reserves to the states all powers not explicitly
23
24
24
Req. No. 1352 Page 1

1
delegated to the federal government, including the authority to
1
2
regulate health and safety within state borders;
2
3
2. Protection of Citizens: It is the responsibility of the
3
4
State of Oklahoma to protect its citizens from harm caused by
4
5
pharmaceutical products, and the state asserts its sovereign
5
6
authority to ensure accountability for those responsible;
6
7
3. Federal Overreach: Federal immunity statutes including, but
7
8
not limited to, the National Childhood Vaccine Injury Act of 1986,
8
9
the Public Readiness and Emergency Preparedness (PREP) Act of 2005,
9
10
the Project Bioshield Act of 2004, and the Defense Production Act of
10
11
1950, which may interfere with the rights of Oklahoma citizens to
11
12
seek justice in state courts and deprive them of adequate remedies
12
13
for harm, which in many cases is very serious or even deadly;
13
14
4. Justice and Accountability: No individual or corporation,
14
15
including pharmaceutical companies, should be shielded from
15
16
liability for harm caused by their actions or products;
16
17
5. Right to Remedy: Article II, Section 6 of the Oklahoma
17
18
Constitution guarantees that “The courts of justice of the State
18
19
shall be open to every person, and speedy and certain remedy
19
20
afforded for every wrong and for every injury to person, property,
20
21
or reputation; and right and justice shall be administered without
21
22
sale, denial, delay, or prejudice.” This act ensures that the
22
23
constitutional rights of Oklahoma citizens are preserved in all
23
24
claims related to pharmaceutical harm; and
24
Req. No. 1352 Page 2

1
6. Legislative Duty: This act is a necessary and proper
1
2
exercise of Oklahoma’s sovereign authority to preserve the health,
2
3
safety, and welfare of its people.
3
4
SECTION 2. NEW LAW A new section of law to be codified
4
5
in the Oklahoma Statutes as Section 9001 of Title 63, unless there
5
6
is created a duplication in numbering, reads as follows:
6
7
As used in this act:
7
8
1. “Fraud” means a deliberate and intentional act to deceive
8
9
another party by misrepresenting, concealing, or omitting a material
9
10
fact to the detriment of the deceived party; and
10
11
2. “Gross negligence” means a conscious, voluntary act or
11
12
omission in reckless disregard of the duty of care, resulting in a
12
13
substantial and unjustifiable risk of harm to another, which a
13
14
reasonable person would consider a gross deviation from acceptable
14
15
standards of conduct.
15
16
SECTION 3. NEW LAW A new section of law to be codified
16
17
in the Oklahoma Statutes as Section 9001.1 of Title 63, unless there
17
18
is created a duplication in numbering, reads as follows:
18
19
A. 1. Any pharmaceutical company whose products are proven to
19
20
directly cause harm to an Oklahoma citizen shall be directly liable
20
21
in Oklahoma state courts for:
21
22
a. compensatory damages including medical expenses, lost
22
23
wages, and other economic losses,
23
24
b. noneconomic damages including pain and suffering, and
24
Req. No. 1352 Page 3

1
c. punitive damages in cases of gross negligence or
1
2
fraud.
2
3
2. Pharmaceutical companies may be criminally prosecuted for
3
4
gross negligence, fraudulent concealment, reckless disregard for
4
5
safety, or intentional harm.
5
6
B. 1. Immunity granted under federal statutes including, but
6
7
not limited to, the National Childhood Vaccine Injury Act of 1986,
7
8
the Public Readiness and Emergency Preparedness (PREP) Act of 2005,
8
9
the Project Bioshield Act of 2004, and the Defense Production Act of
9
10
1950 shall not apply to claims brought in Oklahoma state courts.
10
11
2. Oklahoma asserts its jurisdiction under Article II, Section
11
12
7 of the Oklahoma Constitution and the Tenth Amendment to the
12
13
Constitution of the United States to ensure justice for its
13
14
citizens.
14
15
C. 1. Oklahoma citizens harmed by pharmaceutical products have
15
16
the right to due process under Article II, Section 7 of the Oklahoma
16
17
Constitution.
17
18
2. All claims shall be heard in Oklahoma state courts, with no
18
19
requirement for arbitration or other limitations on access to
19
20
justice.
20
21
SECTION 4. NEW LAW A new section of law to be codified
21
22
in the Oklahoma Statutes as Section 9001.2 of Title 63, unless there
22
23
is created a duplication in numbering, reads as follows:
23
24
24
Req. No. 1352 Page 4

1
To the extent any laws conflict with this act, this act shall
1
2
govern.
2
3
SECTION 5. This act shall become effective July 1, 2025.
3
4
SECTION 6. It being immediately necessary for the preservation
4
5
of the public peace, health or safety, an emergency is hereby
5
6
declared to exist, by reason whereof this act shall take effect and
6
7
be in full force from and after its passage and approval.
7
8
8
9
60-1-1352 DC 1/19/2025 5:43:36 AM
9
10
10
11
11
12
12
13
13
14
14
15
15
16
16
17
17
18
18
19
19
20
20
21
21
22
22
23
23
24
24
Req. No. 1352 Page 5

[DELETED:  P B D]
[DELETED:  P]
[DELETED:  P c n]
[DELETED:  P p]
[DELETED:  P D 1]